retatrutide vs semaglutide vs tirzepatide Mounjaro Ozempic: 2026 Data Is Decisive Semaglutide vs. Tirzepatide vs. Retatrutide:

And women on GLP-1 medications face a specific nutritional risk profile: reduced iron intake from smaller meal volumes compounding pre-existing deficiency, which is more common in menstruating women to begin with (Urbina et al., 2026, 480,825 adults)

0.5 ml syringes (50 units) The 0.5 ml syringe is the most commonly recommended size for GLP-1 injections

Nausea, vomiting, or abdominal pain (Type 1 diabetes with DKA)

Avoiding strength training

The market for nutrition and dietary supplements ostensibly supporting GLP-1 users is projected to more than triple from $4.1 billion in 2025 to $13 billion by 2035, according to research group Future Market Insights Inc